Trial intelligence / Profile preview

Magnesium for Bladder Spasms Following Urologic Procedures

NCT05806996Phase 2Completed

Sponsor
Mayo Clinic
Start
Jun 2023
Primary completion
Jun 2026
Modality
Orthosteric Ligands
Countries
1
01

Overview

Phase 2, randomised trial in bladder spasm comparing Magnesium Group with Placebo Group (2 arms). Primary endpoint: Incidence of bladder spasm at 1 hour. Started Jun 2023; status: completed.

02

Drugs

magnesium
03

Conditions

bladder spasm

Beyond the preview

Go deeper on NCT05806996.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05806996.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call